Slide 1: Q4 FY25 Result Presentation
Q4 FY25 Result Presentation 29 July 2025 Mach7 Technologies | ASX: M7T
Slide 2: Mach7 Technologies delivers advanced data management and diagnostic viewing solutions
Mach7 Technologies delivers advanced data management and diagnostic viewing solutions to healthcare organisations worldwide.
Slide 3: Introducing Mach7's new CEO
Introducing Mach7’s new CEO Teri Thomas commenced as Mach7’s CEO and Managing Director on 1 July 2025 Teri has a distinguished career in healthcare technology, 1 executive leadership and in driving strategic growth. 49% As CEO of Volpara Health Technologies Ltd (ASX:VHT), Teri led a remarkable 58% 3
Slide 4: Q4 FY25 Financial Highlights
Q4 FY25 Financial Highlights Reaffirm updated FY25 guidance1 A$30.2M A$23.1M Operating cash CARR2 Closing Cash flow positive +A$0.5M on 31 Mar 2025 Q4 FY25: A$0.6M A$24.9M at 31 Mar 2025 In constant currency FY25: A$0.7M Strong financial position with no debt A$23.5M A$29.1M On-market share ARR3 Run
Slide 5: First 30 days
First 30 days Do good, have fun, make money Shift customer Position Mach7 Changes to Deep model with for long term Review all areas leadership engagement creation of growth and of the business team,1 with key customer sustained reallocation of stakeholders designated customer resources teams excelle
Slide 6: Immediate Priorities
Immediate Priorities Leverage existing customer base to drive next phase of growth Drive culture of Deliver compelling Sales and innovation customer value marketing flywheel Recent appointment of Chief Identify and align key differentiators to Build customer engagement and Innovation Officer will ac
Slide 7: Transforming our customer engagement
Transforming our customer engagement Six guiding principles to drive customer, sales and marketing flywheel Customers’ long-term success is our true north Growth mindset in all that we do Lowest friction wins Stay connected and have fun Compelling value drives forever customers Deliver consistent Ma
Slide 8: Contact Us
Contact Us Investor Relations, Mach7 Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com Registered Office: Suite 2, Level 11, 385 Bourke St, Melbourne, VIC 3000 This document was authorised for release to the ASX by Teri Thomas, Managing Director and Chief Executive Officer Mach7 Technologies
Slide 9: Disclaimer
Disclaimer “Forward looking” statements Summary of information: This presentation contains general and background information about Mach7 Risks: An investment in M7T securities is subject to investment and other known and unknown risks, Technologies Limited (“M7T”) activities current as at the date